Drug-Related Problems: Clinical Pharmacy and Safety of Pharmacotherapy
A special issue of Medicines (ISSN 2305-6320).
Deadline for manuscript submissions: 30 August 2026 | Viewed by 1423
Special Issue Editors
Interests: pharmaceutical care; clinical pharmacy; pharmacology; pharmacoeconomic
Special Issues, Collections and Topics in MDPI journals
Interests: ethics; bioethics; therapy; law
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The Special Issue aims to highlight pharmacotherapeutic safety. Drug problems such as adverse drug reactions, drug interactions, or pharmacotherapy errors and the possibility of preventing them, detecting them, and examining recent advances in understanding their occurrence are now a challenge for medicine to ensure patient safety.
This Special Issue aims to cover the field of clinical pharmacy services as a tool for ensuring safety in pharmacotherapy.
Drug problems such as adverse drug reactions, drug interactions, dosage errors, or medication administration errors cause many clinical but also economic consequences for the patient as well as the health care system. Many of these drug problems also have ethical implications for medical personnel in particular.
Studies using clinical trials, observational studies, and advanced analytical methods to improve the safety of pharmacotherapy are welcome.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following: drug-related problems, clinical pharmacy, clinical pharmacology, pharmaceutical care, pharmacotherapy, adverse drug reactions, drug interactions, and ethics in scientific research.
We look forward to receiving your contributions.
You may choose our Joint Special Issue in Journal of Clinical Medicine.
Dr. Mariola Drozd
Prof. Dr. Jakub Pawlikowski
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- adverse drug reaction
- drug-related problems
- drug formulation technology
- safety of pharmacotherapy
- clinical pharmacy
- pharmaceutical care
- pharmacology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
